Related references
Note: Only part of the references are listed.Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany - A national case collection
Pawel Kermer et al.
INTERNATIONAL JOURNAL OF STROKE (2017)
Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges
Klaus Fassbender et al.
LANCET NEUROLOGY (2017)
Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Alteplase: A Systematic Review of the Available Evidence
Slaven Pikija et al.
CNS DRUGS (2017)
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Bart M. Demaerschalk et al.
STROKE (2016)
Idarucizumab for Dabigatran Reversal
Charles V. Pollack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Initial experience of a digital training resource for modified Rankin scale assessment in clinical trials
Terence J. Quinn et al.
STROKE (2007)
NIHSS training and certification using a new digital video disk is reliable
P Lyden et al.
STROKE (2005)
Share Paper
